BlackRock’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $82.1M | Sell |
18,365,608
-277,521
| -1% | -$1.29M | ﹤0.01% | 2229 |
|
|
2025
Q4 | $103M | Buy |
18,643,129
+2,278,268
| +14% | +$11.1M | ﹤0.01% | 2098 |
|
|
2025
Q3 | $53.5M | Buy |
16,364,861
+3,061,086
| +23% | +$8.67M | ﹤0.01% | 2454 |
|
|
2025
Q2 | $30.7M | Sell |
13,303,775
-285,403
| -2% | -$620K | ﹤0.01% | 2771 |
|
|
2025
Q1 | $18.9M | Buy |
13,589,178
+57,711
| +0.4% | +$96.5K | ﹤0.01% | 2974 |
|
|
2024
Q4 | $23.4M | Buy |
13,531,467
+10,934
| +0.1% | +$22.7K | ﹤0.01% | 2942 |
|
|
2024
Q3 | $27.2M | Buy |
13,520,533
+1,778,084
| +15% | +$3.9M | ﹤0.01% | 2837 |
|
|
2024
Q2 | $26.3M | Buy |
11,742,449
+9,145,146
| +352% | +$26.6M | ﹤0.01% | 2812 |
|
|
2024
Q1 | $7.45M | Sell |
2,597,303
-101,935
| -4% | -$212K | ﹤0.01% | 3503 |
|
|
2023
Q4 | $4.78M | Buy |
2,699,238
+1,951,170
| +261% | +$3.89M | ﹤0.01% | 3711 |
|
|
2023
Q3 | $2.36M | Buy |
748,068
+427,043
| +133% | +$798K | ﹤0.01% | 3931 |
|
|
2023
Q2 | $212K | Sell |
321,025
-76,460
| -19% | -$55.4K | ﹤0.01% | 4719 |
|
|
2023
Q1 | $317K | Sell |
397,485
-316,572
| -44% | -$409K | ﹤0.01% | 4659 |
|
|
2022
Q4 | $1.61M | Sell |
714,057
-321,592
| -31% | -$651K | ﹤0.01% | 4223 |
|
|
2022
Q3 | $2M | Sell |
1,035,649
-10,841
| -1% | -$39.4K | ﹤0.01% | 4197 |
|
|
2022
Q2 | $3.89M | Sell |
1,046,490
-1,147,213
| -52% | -$4.55M | ﹤0.01% | 3937 |
|
|
2022
Q1 | $14.3M | Sell |
2,193,703
-839,260
| -28% | -$6.27M | ﹤0.01% | 3381 |
|
|
2021
Q4 | $35.3M | Buy |
3,032,963
+10,994
| +0.4% | +$166K | ﹤0.01% | 2913 |
|
|
2021
Q3 | $56.3M | Buy |
3,021,969
+55,198
| +2% | +$1.05M | ﹤0.01% | 2589 |
|
|
2021
Q2 | $62.9M | Buy |
2,966,771
+705,526
| +31% | +$16.3M | ﹤0.01% | 2550 |
|
|
2021
Q1 | $45.9M | Buy |
2,261,245
+31,429
| +1% | +$851K | ﹤0.01% | 2674 |
|
|
2020
Q4 | $59.2M | Buy |
2,229,816
+389,249
| +21% | +$8.39M | ﹤0.01% | 2375 |
|
|
2020
Q3 | $41.2M | Buy |
+1,840,567
| New | +$43.3M | ﹤0.01% | 2411 |
|
Other funds holding TSHA
RCM
ACA
VPC
RI
VCM
OCA